Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Advanced Solid Tumors × talazoparib × 90 days × Clear all

Sponsor

Conditions

Neoplasm Metastasis 5 Breast Neoplasms 5 Prostatic Neoplasms 4 Neoplasms 4 Ovarian Neoplasms 2 mCRPC 1 Wilms Tumor 1 Vaginal Neoplasms 1 Uterine Cervical Neoplasms 1 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Small Cell Lung Carcinoma 1 Sarcoma, Ewing 1 Sarcoma 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Recurrence 1 Pathologic Complete Response 1 Pancreatic Neoplasms 1 Osteosarcoma 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neuroblastoma 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Lung Neoplasms 1 Leukemia 1 Hepatoblastoma 1 Hemangiosarcoma 1 Fallopian Tube Neoplasms 1 Endometrial Neoplasms 1

Interventions

pembrolizumab 5 Injections 4 Bevacizumab 4 Pemetrexed 3 Oxaliplatin 3 Leucovorin 3 Fluorouracil 3 Docetaxel 3 Carboplatin 3 trifluridine tipiracil drug combination 2 Paclitaxel 2 Irinotecan 2 Cetuximab 2 tislelizumab 1 sotorasib 1 palbociclib 1 olaparib 1 netrin-1 inhibitor NP137 1 fludarabine 1 cemiplimab 1 Panitumumab 1 Nivolumab 1 Itraconazole 1 HMPL-013 1 Fulvestrant 1 Etoposide 1 Drug Therapy 1 Cyclophosphamide 1 Cisplatin 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡